Univ Biosensors Inc (UVBIF) 0.2141 $UVBIF
Biosensors Market - Analysis & Forecast to 2020 - Estimated To Reach $22.68 Billion by 2020
M2 - Mon Dec 14, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/29hzlb/biosensors_market) has announced the addition of the "Biosensors Market - Analysis & Forecast to 2020" report to their offering. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices. The global biosensors market is estimated to grow at a CAGR of 10.00% to reach $22.68 Billion by 2020. This report is focused on giving a bird's eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles. Companies Mentioned: - Abbott Point of Care, Inc. - Acon Laboratories, Inc. - Bayer AG - F. Hoffman LA-Roche Ltd. - Lifescan, Inc. - Lifesensors Inc. - Medtronic Inc. - Nova Biomedical Corporation - Pharmaco-Kinesis Corporation - Siemens AG - Universal Biosensors Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends7 Biosensors Market By Application 8 Biosensors Market, By Technology 9 Biosensors Market, By Product 10 Biosensors Market, By Geography 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/29...ors_market
MDT: 87.42 (-0.06)
Biosensors Market Analysis 2015 By Application, By Technology And Segment - Forecasts To 2020 for the $21 Billion Industry
M2 - Mon Nov 02, 4:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/k67mxs/biosensors_market) has announced the addition of the "Biosensors Market Analysis By Application, By Technology And Segment - Forecasts To 2020" report to their offering. Global biosensors market is expected to reach USD 21.17 billion by 2020 Biosensors, owing to their capability to resolve various analytical issues in diverse areas such as medicine, pharmacology, food & agriculture safety and defense, are expected to witness a rapid growth in demand over the next six years. Increasing demand for specific detection techniques for early diagnosis in the healthcare sector is expected to drive the overall biosensors market during the forecast period. Furthermore, the expanding role of biosensors in the real world environment has led to a hike in R&D efforts globally. Further key findings from the study suggest: - Optical biosensors are identified as the most lucrative technology segment of this market and are expected to grow at a CAGR of over 7.0% during the forecast period. Growing use of these sensors in the field of environmental scanning is one of the key drivers of this market. The recent progress in optical biosensors has made them apt for environmental scanning wherein they are used for quantifying and characterizing environmental pollutants. - Biosensors are mostly used in devices enabled with point of care testing. The biosensors based point of care testing segment accounted for over 40% of the end-use market in 2013. Moreover, rising demand for portable and integrated technologies that can be operated by untrained personnel outside conventional laboratories is expected to improve usage rates. - North America accounted for more than 35% of the market in 2013. Biosensors witness the highest market penetration rates in this region owing to the presence of high procedure volumes supported by favorable government initiatives. Moreover, rapidly growing demand for point of care and home healthcare markets in the U.S. is expected to drive regional market growth during the forecast period. - Asia Pacific has high future growth potential owing to the presence of large untapped opportunities in the emerging markets of India and China. Presence of favorable government initiatives aimed at improving environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to serve as a high impact rendering driver for this market. - Key players of this market include Abbott Point of Care Inc., Roche, Lifescan Inc., Bayer AG, Medtronic Inc., Universal Biosensors, Siemens Healthcare and Nova Biomedical Corporation. For the purpose of this study, the report has segmented the global biosensors market on the basis of application, technology and end-use: Global Biosensors Application Outlook (Market Revenue in USD Million, 2012 - 2020) - Medical Applications - Cholesterol Testing - Blood Glucose Monitoring - Blood Gas Analyzer - Pregnancy Testing - Drug Discovery - Infectious Diseases - Food Toxicity Detection - Industrial Process Control (Bioreactor) - Agriculture - Environment - Others Global Biosensors Technology Outlook (Market Revenue in USD Million, 2012 - 2020) - Thermal Biosensors - Electrochemical Biosensors - Piezoelectric Biosensors - Optical Biosensors Global Biosensors End-use Outlook (Market Revenue in USD Million, 2012 - 2020) - Home Healthcare Diagnostics - Point of Care Testing - Food Industry - Research Laboratories - Security and Bio-Defense For more information visit http://www.researchandmarkets.com/research/k6...ors_market
MDT: 87.42 (-0.06)
Coagulation Self-Testing Market to 2020
M2 - Mon Jun 29, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fn4qg2/coagulation) has announced the addition of the "Coagulation Self-testing to 2020" report to their offering. The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) -a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing. The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete. What You Will Learn - What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy? - What is the status and prospects of coagulation self-test devices currently in development? - What is the market potential and commercialization risks and opportunities for coagulation self-test devices? - What are the key patient self-test device design issues and evolving market factors for coagulation self-testing? - What is the impact of coagulation self-test technology and devices on coagulation management markets? - What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance? - Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies? - Who are the market leaders; what is the size of the market today, and what will it be in 2020? - What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices? Key Topics Covered: 1. Executive Summary 2. Anticoagulation Therapy Market Dynamics - Anticoagulation Healthcare Economics - Oral Anticoagulation Therapy - Monitoring Prothrombin Time - Competing Coagulation Tests - Key Factors in Patient Compliance - Market Drivers - Industry Alignment and Competitive Landscape 3. Coagulation Self-Testing Device Design Factors - Standardization of PT/INR Testing - Accuracy and Precision - Sampling Method - Endpoint Detection - Patient/User Interface - Wireless Technology 4. Commercialization Factors - Managed Care and Reimbursement - Third-party Patient Training & Support - Proprietary Technology 5. Market Factors - Indications and Market Segments - Novel Oral Anticoagulants - Patient Demographics - Regulations and Standards - Patient/Consumer Sentiment 6. Patient Self-Testing Product Assessments - Commercial Products - CoaguChek - CoaguSense - InRatio - i-STAT 7. Development-Stage Devices - iLine Microsystems - Microvisk - Universal Biosensors - FlexLife Health 8. Market Analysis, Data and Forecasts - North America - Western Europe - Eastern Europe - Asia - MENA - South America 9. Company Profiles For more information visit http://www.researchandmarkets.com/research/fn...oagulation
Global Bio-Electronics Market 2015-2020 - Applications Overview, Challenges, Opportunities, Segmentation & Forecasts
M2 - Wed May 13, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twdkgc/global) has announced the addition of the "Global Bio-Electronics Market By Applications Overview, Challenges, Opportunities, Segmentation, Forecast 2015-2020" report to their offering. Bioelectronics involves application of principles of electrical engineering to biology, medicine, behavior, or health. It helps to come up with advanced concepts, improves knowledge across molecular to organ systems, and aids in the development of innovative devices or processes. This further helps in prevention, diagnosis, and treatment of diseases resulting in better diagnosis, rehabilitation and health. Bioelectronics helps to create and evaluate new technologies which improve understanding of biological systems, increasing efficiency and effectiveness of the medical community. Bioelectronics uses a number of methods, ideas, and techniques, such as bioelectromagnetics, instrumentation, neural networks, robotics, and sensor technologies. This synergy between electronics and biology has resulted in a positive impact of electronic technologies to system, cell, and molecular biology. Experts expect the technologies to have far reaching effects such as vision restoration, reversing the effects of spinal cord injury, medical diagnoses without clinics, etc. The drivers to bio-electronics industry include the overwhelming need of the healthcare industry. These include prevention of diseases such as neural degeneration, cancer, etc., detection of diseases, personalized medical diagnostics and monitoring among others. Applications such as personalized medical diagnostics and monitoring especially present near-term application opportunities. Other drivers include implantable medical devices and prosthetics, which have seen a lot of research to develop reliable and robust implantable devices. Medical imaging either requires high-resolution imaging or portable and affordable imaging systems and these can be met with innovations from the bio-electronics industry. Capability & Market Analysis: Currently Europe is making a huge impact in the industry with most of the research and innovations coming from there followed by Asia and the United States. Industry experts estimate that United States is likely to register the highest growth in terms of contribution due to the high instances of research and investment in biomedicine and semiconductors in the country. Currently, biomedical and life sciences applications have the largest market share among applications followed by environmental monitoring and remediation applications. Key Topics Covered: Chapter 1. Introduction Chapter 2. Market Overview Chapter 3. Market Segmentation Chapter 4. Sector Analysis Chapter 5. Key Company And Strategic Analysis Chapter 6. Geographical Analysis Chapter 7. Company Profiling - Bioelectronics Corporation - Avago - Honeywell International - Danaher Corporation - Omnivision Technologies - Sensirion - Medtronics - BodyMedia - Sotera Wireless - Siemens AG - Roche - Universal Biosensors - Abbott - Beckman Coulter - Life Sensors For more information visit http://www.researchandmarkets.com/research/twdkgc/global
HON: 115.76 (+0.80), DHR: 81.18 (+0.33)
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 24.34 (+0.68), MDT: 87.42 (-0.06)
Biosensors Market - Analysis & Forecast to 2020 - Estimated To Reach $22.68 Billion by 2020
M2 - Mon Dec 14, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/29hzlb/biosensors_market) has announced the addition of the "Biosensors Market - Analysis & Forecast to 2020" report to their offering. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices. The global biosensors market is estimated to grow at a CAGR of 10.00% to reach $22.68 Billion by 2020. This report is focused on giving a bird's eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles. Companies Mentioned: - Abbott Point of Care, Inc. - Acon Laboratories, Inc. - Bayer AG - F. Hoffman LA-Roche Ltd. - Lifescan, Inc. - Lifesensors Inc. - Medtronic Inc. - Nova Biomedical Corporation - Pharmaco-Kinesis Corporation - Siemens AG - Universal Biosensors Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends7 Biosensors Market By Application 8 Biosensors Market, By Technology 9 Biosensors Market, By Product 10 Biosensors Market, By Geography 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/29...ors_market
MDT: 87.42 (-0.06)
Biosensors Market Analysis 2015 By Application, By Technology And Segment - Forecasts To 2020 for the $21 Billion Industry
M2 - Mon Nov 02, 4:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/k67mxs/biosensors_market) has announced the addition of the "Biosensors Market Analysis By Application, By Technology And Segment - Forecasts To 2020" report to their offering. Global biosensors market is expected to reach USD 21.17 billion by 2020 Biosensors, owing to their capability to resolve various analytical issues in diverse areas such as medicine, pharmacology, food & agriculture safety and defense, are expected to witness a rapid growth in demand over the next six years. Increasing demand for specific detection techniques for early diagnosis in the healthcare sector is expected to drive the overall biosensors market during the forecast period. Furthermore, the expanding role of biosensors in the real world environment has led to a hike in R&D efforts globally. Further key findings from the study suggest: - Optical biosensors are identified as the most lucrative technology segment of this market and are expected to grow at a CAGR of over 7.0% during the forecast period. Growing use of these sensors in the field of environmental scanning is one of the key drivers of this market. The recent progress in optical biosensors has made them apt for environmental scanning wherein they are used for quantifying and characterizing environmental pollutants. - Biosensors are mostly used in devices enabled with point of care testing. The biosensors based point of care testing segment accounted for over 40% of the end-use market in 2013. Moreover, rising demand for portable and integrated technologies that can be operated by untrained personnel outside conventional laboratories is expected to improve usage rates. - North America accounted for more than 35% of the market in 2013. Biosensors witness the highest market penetration rates in this region owing to the presence of high procedure volumes supported by favorable government initiatives. Moreover, rapidly growing demand for point of care and home healthcare markets in the U.S. is expected to drive regional market growth during the forecast period. - Asia Pacific has high future growth potential owing to the presence of large untapped opportunities in the emerging markets of India and China. Presence of favorable government initiatives aimed at improving environmental conditions and enhancing healthcare infrastructure in Japan and Australia are also expected to serve as a high impact rendering driver for this market. - Key players of this market include Abbott Point of Care Inc., Roche, Lifescan Inc., Bayer AG, Medtronic Inc., Universal Biosensors, Siemens Healthcare and Nova Biomedical Corporation. For the purpose of this study, the report has segmented the global biosensors market on the basis of application, technology and end-use: Global Biosensors Application Outlook (Market Revenue in USD Million, 2012 - 2020) - Medical Applications - Cholesterol Testing - Blood Glucose Monitoring - Blood Gas Analyzer - Pregnancy Testing - Drug Discovery - Infectious Diseases - Food Toxicity Detection - Industrial Process Control (Bioreactor) - Agriculture - Environment - Others Global Biosensors Technology Outlook (Market Revenue in USD Million, 2012 - 2020) - Thermal Biosensors - Electrochemical Biosensors - Piezoelectric Biosensors - Optical Biosensors Global Biosensors End-use Outlook (Market Revenue in USD Million, 2012 - 2020) - Home Healthcare Diagnostics - Point of Care Testing - Food Industry - Research Laboratories - Security and Bio-Defense For more information visit http://www.researchandmarkets.com/research/k6...ors_market
MDT: 87.42 (-0.06)
Coagulation Self-Testing Market to 2020
M2 - Mon Jun 29, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fn4qg2/coagulation) has announced the addition of the "Coagulation Self-testing to 2020" report to their offering. The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) -a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing. The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete. What You Will Learn - What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy? - What is the status and prospects of coagulation self-test devices currently in development? - What is the market potential and commercialization risks and opportunities for coagulation self-test devices? - What are the key patient self-test device design issues and evolving market factors for coagulation self-testing? - What is the impact of coagulation self-test technology and devices on coagulation management markets? - What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance? - Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies? - Who are the market leaders; what is the size of the market today, and what will it be in 2020? - What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices? Key Topics Covered: 1. Executive Summary 2. Anticoagulation Therapy Market Dynamics - Anticoagulation Healthcare Economics - Oral Anticoagulation Therapy - Monitoring Prothrombin Time - Competing Coagulation Tests - Key Factors in Patient Compliance - Market Drivers - Industry Alignment and Competitive Landscape 3. Coagulation Self-Testing Device Design Factors - Standardization of PT/INR Testing - Accuracy and Precision - Sampling Method - Endpoint Detection - Patient/User Interface - Wireless Technology 4. Commercialization Factors - Managed Care and Reimbursement - Third-party Patient Training & Support - Proprietary Technology 5. Market Factors - Indications and Market Segments - Novel Oral Anticoagulants - Patient Demographics - Regulations and Standards - Patient/Consumer Sentiment 6. Patient Self-Testing Product Assessments - Commercial Products - CoaguChek - CoaguSense - InRatio - i-STAT 7. Development-Stage Devices - iLine Microsystems - Microvisk - Universal Biosensors - FlexLife Health 8. Market Analysis, Data and Forecasts - North America - Western Europe - Eastern Europe - Asia - MENA - South America 9. Company Profiles For more information visit http://www.researchandmarkets.com/research/fn...oagulation
Global Bio-Electronics Market 2015-2020 - Applications Overview, Challenges, Opportunities, Segmentation & Forecasts
M2 - Wed May 13, 6:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/twdkgc/global) has announced the addition of the "Global Bio-Electronics Market By Applications Overview, Challenges, Opportunities, Segmentation, Forecast 2015-2020" report to their offering. Bioelectronics involves application of principles of electrical engineering to biology, medicine, behavior, or health. It helps to come up with advanced concepts, improves knowledge across molecular to organ systems, and aids in the development of innovative devices or processes. This further helps in prevention, diagnosis, and treatment of diseases resulting in better diagnosis, rehabilitation and health. Bioelectronics helps to create and evaluate new technologies which improve understanding of biological systems, increasing efficiency and effectiveness of the medical community. Bioelectronics uses a number of methods, ideas, and techniques, such as bioelectromagnetics, instrumentation, neural networks, robotics, and sensor technologies. This synergy between electronics and biology has resulted in a positive impact of electronic technologies to system, cell, and molecular biology. Experts expect the technologies to have far reaching effects such as vision restoration, reversing the effects of spinal cord injury, medical diagnoses without clinics, etc. The drivers to bio-electronics industry include the overwhelming need of the healthcare industry. These include prevention of diseases such as neural degeneration, cancer, etc., detection of diseases, personalized medical diagnostics and monitoring among others. Applications such as personalized medical diagnostics and monitoring especially present near-term application opportunities. Other drivers include implantable medical devices and prosthetics, which have seen a lot of research to develop reliable and robust implantable devices. Medical imaging either requires high-resolution imaging or portable and affordable imaging systems and these can be met with innovations from the bio-electronics industry. Capability & Market Analysis: Currently Europe is making a huge impact in the industry with most of the research and innovations coming from there followed by Asia and the United States. Industry experts estimate that United States is likely to register the highest growth in terms of contribution due to the high instances of research and investment in biomedicine and semiconductors in the country. Currently, biomedical and life sciences applications have the largest market share among applications followed by environmental monitoring and remediation applications. Key Topics Covered: Chapter 1. Introduction Chapter 2. Market Overview Chapter 3. Market Segmentation Chapter 4. Sector Analysis Chapter 5. Key Company And Strategic Analysis Chapter 6. Geographical Analysis Chapter 7. Company Profiling - Bioelectronics Corporation - Avago - Honeywell International - Danaher Corporation - Omnivision Technologies - Sensirion - Medtronics - BodyMedia - Sotera Wireless - Siemens AG - Roche - Universal Biosensors - Abbott - Beckman Coulter - Life Sensors For more information visit http://www.researchandmarkets.com/research/twdkgc/global
HON: 115.76 (+0.80), DHR: 81.18 (+0.33)
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 24.34 (+0.68), MDT: 87.42 (-0.06)
